Following positive clinical findings , retatrutide, a novel peptide therapy for addressing type 2 diabetes , has secured regulatory approval from Great Britain's Medicines and Products Agency ( MHRA https://imogenuhsb469559.collectblogs.com/85678713/retatrutide-compound-peptide-british-authorization-and-launch